Tricia Larose

Tumors in Space is funded by a program under the European Space Agency (ESA) with the support of the Norwegian Space Agency. Tricia aims to identify a unique mutational signature of cosmic radiation for early detection of cancer among astronauts and jet-fighter pilots. She also aims to slow or stop the growth by exposing cancer patient derived tumor organoids to the microgravity environment. As of summer 2022, Tumors in Space is in preparation for three spaceflights including the Polaris Dawn mission with Space X (scientific demonstration), the International Space Station with ICE Cubes Service (hardware demonstration), and the China Space Station coordinated by the United Nations Office for Outer Space Affairs (31-day mission). Tricia holds a PhD in Medicine from the Norwegian University of Science and Technology and is an alumna of the London School of Hygiene and Tropical Medicine (England) and Laurentian University (Canada). She is an adjunct faculty member in Human Performance in Space with the International Space University (France), and a Scientist-Astronaut Candidate with Project PoSSUM (USA). Tricia is a recognized Thought Leader within the "Tissues, Organoids and Spheroids for Space – Microgravity for Personalized Medicine (M4PM)" community funded by ESA. She is originally from Sudbury, Ontario, Canada – home of her favorite hockey team, The Sudbury Wolves.